Draft Patents (Amendment), Rules, 2023
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
Patents
-
Evergreening A controversial issue in pharma milieu
A patent is an exclusive right awarded by the intellectual property (IP) authority of a state to an inventor or his assignee for a limited period of time in lieu of disclosure of an invention for the benefit of mankind. In recent times, it has become a practice by a number of innovator companies to extend the patent term of their innovative molecules to maintain market dominance.
-
Say cheese to Brussels
A free-trade pact with EU will weaken India
-
News 360 - Briefs
patent Human genes create stir in US About 100,000 cancer patients, doctors, researchers and lawyers sued the US government for granting patents for two human genes. They said the patents deny women with breast and ovarian cancer the benefit of new tests and possible treatment. A company or an institution that owns patents for genes has specific rights to their use, which may
-
UNITAID, drug cos discuss patent pool
Khomba Singh NEW DELHI IN a move aimed to ensure supply of low-cost HIV drugs globally, UNITAID, an international facility for purchase of drugs against HIV/AIDS, malaria and tuberculosis (TB), held discussions with Indian generic drug makers on Tuesday to develop the world
-
New study on protecting drugs in India
A MAJOR new study identifying a broad range of potential benefits of incremental pharmaceutical innovation for India will be released at the US-India Business Council
-
India loses patents due to improper documentation
June 16: India is losing over 2,000 patents every year on traditional formulations as they were never properly documented, the Union minister for state and environment, Mr Jairam Ramesh, said here on Tuesday.
-
Microbes can be patented
Mashelkar report says modified organisms are intellectual property THE expert group on patent law headed by R A Mashelkar has recommended that microbes like bacteria, fungi and virus should be patented if they have been modified. The committee has also said India cannot limit its patents to new chemical substances in pharmaceutical products. The recommendations were submitted to the Union
-
Make 'Flame' but don't sell it: SC to TVS
The Supreme Court today allowed Chennai-headquartered TVS Motor Co to manufacture
-
The value of incremental pharmaceutical innovation: benefits for Indian patients and Indian business
Improved quality of drug products in India, including products that are better suited to India
-
Innovation and technology transfer to address climate change
This paper examines issues surrounding the development and transfer of technologies for addressing the problem of climate change based on the experience of developing countries in addressing problems of innovation and access in the fi eld of medicines.